Cargando…

What Can IBD Specialists Learn from IL-23 Trials in Dermatology?

BACKGROUND AND AIMS: The advent of biologic drugs revolutionised the treatment of many chronic inflammatory diseases in rheumatology, dermatology, and gastroenterology. The introduction of different targeted agents closely followed the increase in knowledge of pathogenic mechanisms. The identificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenti, Mario, Narcisi, Alessandra, Pavia, Giulia, Gargiulo, Luigi, Costanzo, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097670/ https://www.ncbi.nlm.nih.gov/pubmed/35553663 http://dx.doi.org/10.1093/ecco-jcc/jjac023

Ejemplares similares

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
por: Valenti, Mario, et al.
Publicado: (2022)

IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
por: McDonald, Benjamin D, et al.
Publicado: (2022)

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
por: Gargiulo, Luigi, et al.
Publicado: (2022)

IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)

Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report
por: Facheris, Paola, et al.
Publicado: (2020)

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
por: Cortese, Andrea, et al.
Publicado: (2023)

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
por: Gargiulo, Luigi, et al.
Publicado: (2022)

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study
por: BORRONI, Riccardo G., et al.
Publicado: (2021)

IL-23 and axial disease: do they come together?
por: Mease, Philip, et al.
Publicado: (2021)

IL-23 orchestrating immune cell activation in arthritis
por: Najm, Aurélie, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
por: Rose, Keeley L, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
por: Shaffer, Seth R, et al.
Publicado: (2023)

Biomarkers in IBD: What to Utilize for the Diagnosis?
por: D’Incà, Renata, et al.
Publicado: (2023)

Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints
por: Łukasik, Zuzanna, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
por: El-Matary, Wael, et al.
Publicado: (2023)

Real-Life Safety and Effectiveness of Dupilumab in Patients with Concomitant Malignancies: a Case Series
por: Gargiulo, Luigi, et al.
Publicado: (2023)

IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant
por: Sun, Rui, et al.
Publicado: (2020)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
por: Jamka, Leslie P, et al.
Publicado: (2019)

All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
por: Jefremow, André, et al.
Publicado: (2020)

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)
por: Narcisi, Alessandra, et al.
Publicado: (2022)

PERCH in Perspective: What Can It Teach Us About Pneumonia Etiology in Children?
por: Klugman, Keith P., et al.
Publicado: (2017)

Closed-Loop Adaptive Neurostimulation Technologies in Cognitive Rehabilitation of High-Tech Specialists
por: Fedotchev, A.I.
Publicado: (2022)

“Mild” COPD: What Spirometry Conceals!
por: O’Donnell, Denis E.
Publicado: (2017)

Blockade of IL-23: What is in the Pipeline?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

Teledermatology reduces dermatology referrals and improves access to specialists
por: Giavina-Bianchi, Mara, et al.
Publicado: (2020)

IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease
por: Einarsdottir, Elisabet, et al.
Publicado: (2009)

Interleukin-23 in perspective
por: Sherlock, Jonathan P, et al.
Publicado: (2021)

Viral Infections of the Lower Respiratory Tract: Old Viruses, New Viruses, and the Role of Diagnosis
por: Pavia, Andrew T.
Publicado: (2011)

What Can Modeling Tell Us About Sustainable End Points for Neglected Tropical Diseases?
por: Minter, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1eno8vtjoo4shu9ma9bev6a9b